Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Chemical Allergen [EPC]
Polysorbate 80 is a non-ionic surfactant and emulsifier used in pharmaceuticals, foods, and cosmetics. While generally recognized as safe, it is classified as a non-standardized chemical allergen [EPC] due to its potential to trigger hypersensitivity reactions in sensitive individuals.
Name
Polysorbate 80
Raw Name
POLYSORBATE 80
Category
Non-Standardized Chemical Allergen [EPC]
Drug Count
8
Variant Count
13
Last Verified
February 17, 2026
RxCUI
1241471, 1535485, 1098362
UNII
K679OBS311, PDC6A3C0OX, 6OZP39ZG8H, MZ1131787D, 3NXW29V3WO, 89DS0H96TB
About Polysorbate 80
Polysorbate 80 is a non-ionic surfactant and emulsifier used in pharmaceuticals, foods, and cosmetics. While generally recognized as safe, it is classified as a non-standardized chemical allergen [EPC] due to its potential to trigger hypersensitivity reactions in sensitive individuals.
Detailed information about Polysorbate 80
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Polysorbate 80.
Polysorbate 80, also known by the trade name Tween 80, is a non-ionic surfactant and emulsifier derived from polyethoxylated sorbitan and oleic acid. In the realm of clinical pharmacology, it is classified by the FDA as a Non-Standardized Chemical Allergen [EPC]. While it is not a primary therapeutic drug intended to treat a specific disease, it is an ubiquitous excipient (an inactive substance used as a carrier) in thousands of pharmaceutical formulations, including vaccines, monoclonal antibodies, and intravenous (IV) medications.
Polysorbate 80 belongs to the class of polyoxyethylene sorbitan fatty acid esters. Its primary role in medicine is to stabilize aqueous formulations of medications, preventing the aggregation of proteins and ensuring that fat-soluble ingredients remain evenly dispersed in water-based solutions. Despite its status as an 'inactive' ingredient, Polysorbate 80 is pharmacologically active in the sense that it can influence the bioavailability of other drugs and, in rare cases, provoke significant immunological responses. It was first approved for use in various capacities by the FDA in the mid-20th century and remains a cornerstone of modern drug delivery systems.
At the molecular level, Polysorbate 80 works through its amphiphilic properties—meaning it possesses both a hydrophilic (water-loving) head and a lipophilic (fat-loving) tail. This structure allows it to reduce the surface tension between two liquids that would otherwise not mix, such as oil and water.
In pharmaceutical formulations, Polysorbate 80 forms micelles (spherical structures) around hydrophobic (water-insoluble) drug molecules. This 'encapsulation' allows the drug to be effectively dissolved in an aqueous environment, which is critical for intravenous administration where the drug must enter the bloodstream directly. Furthermore, in the context of biologics (drugs derived from living organisms), Polysorbate 80 acts as a stabilizer. It coats the surface of proteins or viral particles, preventing them from sticking to the glass walls of vials or syringes and protecting them from mechanical stress during shipping and handling.
Research has also explored the role of Polysorbate 80 in crossing the blood-brain barrier (BBB). Because of its surfactant properties, it can temporarily coat nanoparticles, potentially allowing them to bypass the tight junctions of the BBB, though this remains an area of active clinical investigation rather than a standard approved use.
Polysorbate 80 is utilized in a vast array of FDA-approved products. Its primary indications include:
Polysorbate 80 is almost never prescribed as a standalone product. Instead, it is found in:
> Important: Only your healthcare provider can determine if a medication containing Polysorbate 80 is appropriate for you, especially if you have a history of sensitivities to surfactants.
There is no standard 'dose' for Polysorbate 80 because it is an excipient. However, the World Health Organization (WHO) and the Joint FAO/WHO Expert Committee on Food Additives (JECFA) have established an Acceptable Daily Intake (ADI) for polysorbates.
Polysorbate 80 is present in many pediatric vaccines and medications. While generally safe, the dosage is strictly controlled by the formulation of the specific medication being administered.
Because the polyoxyethylene sorbitan portion of the molecule is cleared by the kidneys, healthcare providers may exercise caution when administering high-dose IV medications containing Polysorbate 80 to patients with severe renal failure (Stage 4 or 5 CKD). However, standard adjustments are rarely required for the Polysorbate 80 component itself.
Since the metabolism of the oleic acid component occurs in the liver, patients with severe hepatic cirrhosis may theoretically process the lipid portion more slowly. In practice, this is rarely clinically significant compared to the primary drug's metabolism.
No specific dosage adjustments for Polysorbate 80 are required for the elderly, though providers should monitor for increased sensitivity to the active drugs that Polysorbate 80 helps deliver.
As Polysorbate 80 is a component of other medications, you must follow the specific instructions for that medication.
If you miss a dose of a medication containing Polysorbate 80, contact your healthcare provider. Do not 'double up' on doses to catch up, as this could increase your exposure to both the active drug and the excipient.
An overdose of Polysorbate 80 is extremely rare and usually only occurs in the context of an overdose of the primary medication it is formulated with.
> Important: Follow your healthcare provider's dosing instructions for any medication containing Polysorbate 80. Do not adjust your dose without medical guidance.
Most patients do not experience side effects directly from Polysorbate 80, as it is usually present in small amounts. However, when used in higher concentrations (such as in certain IV medications), common reactions may include:
> Warning: Stop using the medication and call your doctor immediately if you experience any of the following symptoms of a severe allergic reaction.
There is no clinical evidence suggesting that Polysorbate 80 accumulates in the body or causes long-term organ damage when used within the established ADI limits. In the context of chronic conditions (like using eye drops daily for years), the most common long-term effect is localized irritation or sensitivity to the surfactant.
No FDA black box warnings currently exist specifically for Polysorbate 80. However, many medications that contain Polysorbate 80 (such as certain chemotherapy agents) carry their own black box warnings. It is essential to read the full prescribing information for the specific drug you are taking.
Report any unusual symptoms or persistent side effects to your healthcare provider immediately. If you have a known allergy to Polysorbate 80 or Polyethylene Glycol (PEG), ensure this is documented in your medical record.
Polysorbate 80 is generally safe for the vast majority of the population. However, its classification as a non-standardized chemical allergen means that individuals with unexplained sensitivities to various medications or processed foods should be evaluated for polysorbate allergy.
There are no FDA black box warnings for Polysorbate 80 as a standalone substance. It is classified as 'Generally Recognized as Safe' (GRAS) for food use and is a standard pharmaceutical excipient.
Patients with a history of 'idiopathic anaphylaxis' (anaphylaxis with no known cause) may actually be sensitive to Polysorbate 80. Because it is closely related to Polyethylene Glycol (PEG), cross-sensitivity can occur. If you have had a severe reaction to a COVID-19 vaccine (specifically the mRNA vaccines which contain PEG) or the Janssen vaccine (which contains Polysorbate 80), you must consult an allergist before receiving further doses or other medications containing these surfactants.
No specific lab tests are required to monitor Polysorbate 80 levels in the blood. However, if a patient is undergoing chemotherapy with a drug formulated in Polysorbate 80 (like Docetaxel), healthcare providers will monitor:
Polysorbate 80 itself does not cause drowsiness or impairment. However, the medications it is paired with (such as sedative-containing IV cocktails) may significantly affect your ability to drive. Always follow the specific guidance for the primary medication.
There are no direct interactions between alcohol and Polysorbate 80. However, alcohol can increase the permeability of the gut lining, which might theoretically alter the absorption of surfactants. Consult your doctor regarding alcohol consumption if you are on a treatment regimen containing this excipient.
There is no 'withdrawal syndrome' associated with Polysorbate 80. It can be discontinued safely at any time, provided the primary medication it is part of does not require a tapering schedule (e.g., steroids or certain antidepressants).
> Important: Discuss all your medical conditions and known allergies with your healthcare provider before starting any treatment containing Polysorbate 80.
There are no drugs that are strictly contraindicated with Polysorbate 80 due to chemical incompatibility. However, if a patient has a documented anaphylactic allergy to Polysorbate 80, any medication containing it is contraindicated. The clinical consequence of use in such patients is life-threatening anaphylaxis.
Polysorbate 80 can act as a 'permeability enhancer.' This means it can sometimes increase the absorption of other drugs more than intended.
Polysorbate 80 does not typically interfere with standard blood chemistry or hematology tests. However, in very high concentrations in a blood sample, surfactants can theoretically interfere with certain 'immunoassays' (tests that use antibodies to measure substance levels) by disrupting the antibody-antigen binding. This is a rare technical issue for the lab and not a health risk to the patient.
The primary mechanism for interactions involving Polysorbate 80 is micellar solubilization. By trapping drug molecules in micelles, it prevents them from precipitating but also changes how they interact with cell membranes. The clinical consequence is usually an increase in the rate or extent of absorption (increased bioavailability).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you are starting a new IV therapy.
Polysorbate 80 must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients should be aware that Polysorbate 80 is structurally related to:
If you have reacted to any of these substances in the past, you may be at a higher risk of reacting to Polysorbate 80.
> Important: Your healthcare provider will evaluate your complete medical history and allergy profile before prescribing any medication containing Polysorbate 80.
Polysorbate 80 is generally considered safe when consumed in standard dietary amounts during pregnancy.
It is unknown if intact Polysorbate 80 is excreted in human milk. However, because it is rapidly broken down into oleic acid and sorbitan esters—both of which are normal components of the diet—it is highly unlikely to pose a risk to a nursing infant. Most experts consider it compatible with breastfeeding.
Polysorbate 80 is widely used in pediatric medicine, especially in vaccines.
There are no specific restrictions for the use of Polysorbate 80 in the elderly.
In patients with a Glomerular Filtration Rate (GFR) below 30 mL/min, the clearance of the polyoxyethylene sorbitan metabolite may be delayed. While no specific dose reductions are usually published for the excipient, the physician may monitor the patient more closely for systemic signs of surfactant sensitivity.
No adjustments are typically needed for patients with liver disease (Child-Pugh Class A, B, or C). The metabolism of the oleic acid component is handled by the liver's fatty acid pathways, which usually remain functional even in significant liver disease.
> Important: Special populations require individualized medical assessment by a qualified healthcare professional.
Polysorbate 80 is a non-ionic surfactant. Its molecular mechanism involves the reduction of interfacial tension. In a solution containing both water and oil, Polysorbate 80 molecules orient themselves at the interface; the polyoxyethylene groups face the water, while the oleic acid tail faces the oil. This stabilizes the mixture, preventing droplets from coalescing (sticking together). In protein-based drugs, it prevents 'adsorption,' where proteins stick to the surface of the container and unfold (denature).
Polysorbate 80 does not have a traditional dose-response relationship for a therapeutic effect because it is not used to treat a disease. However, its 'surfactant effect' is concentration-dependent. Above a certain concentration, known as the Critical Micelle Concentration (CMC), Polysorbate 80 molecules spontaneously form micelles, which is the key to its ability to dissolve hydrophobic drugs.
| Parameter | Value |
|---|---|
| Bioavailability | <5% (Oral); 100% (IV) |
| Protein Binding | Minimal/Insignificant |
| Half-life | 1.5 - 4 hours (Metabolites) |
| Tmax | ~1 hour (Oral) |
| Metabolism | Hydrolysis via Plasma Esterases |
| Excretion | Renal (Sorbitan moiety); Fecal (Trace) |
Polysorbate 80 is classified as a Non-ionic Surfactant and an Emulsifying Agent. In the context of drug allergies, it is categorized as a Non-Standardized Chemical Allergen [EPC]. Related substances include Polysorbate 20 (Tween 20) and various Polyethylene Glycols (PEGs).
Common questions about Polysorbate 80
Polysorbate 80 is primarily used as an emulsifier and stabilizer in both the food and pharmaceutical industries. In medicine, it helps dissolve poorly soluble drugs in water-based solutions, making them safe for intravenous injection. It is also a critical component in many vaccines, where it prevents the active ingredients from sticking to the sides of the vial. Additionally, it is found in many everyday items like ice cream, lotions, and eye drops. Its main role is to ensure that mixtures of oil and water remain stable and effective over time.
For the vast majority of people, Polysorbate 80 causes no side effects at all because it is used in very small quantities. When side effects do occur, they are most often localized to the site of an injection, appearing as mild redness, swelling, or itching. Some people may experience temporary flushing or a warm sensation if a medication containing it is infused too quickly. In very rare cases, individuals with a specific sensitivity may develop hives or a rash. Serious allergic reactions are extremely uncommon but require immediate medical attention.
There is no known direct chemical interaction between Polysorbate 80 and alcohol. However, since Polysorbate 80 is always an ingredient in another medication, you must check if alcohol interacts with the *active* drug you are taking. For example, if the medication is a sedative or a chemotherapy agent, alcohol could significantly increase the risk of side effects. Alcohol can also irritate the stomach lining, which might worsen any mild digestive upset caused by oral supplements containing surfactants. Always consult your doctor about your alcohol consumption during treatment.
Polysorbate 80 is generally considered safe during pregnancy when consumed in the amounts typically found in food and standard medications. It has been used for decades in various healthcare products without a clear link to birth defects or pregnancy complications. However, because most clinical trials for new drugs exclude pregnant women, data on high-dose intravenous exposure is more limited. If you are pregnant, your healthcare provider will weigh the necessity of the medication against any theoretical risks. Always inform your obstetrician about all supplements and medications you are using.
As an inactive ingredient, Polysorbate 80 'works' the moment it is formulated into a product by keeping the ingredients stable. When you receive a medication containing it, the Polysorbate 80 begins its job of helping the drug disperse in your system immediately upon administration. It does not have a 'therapeutic onset' time like a painkiller or an antibiotic because it doesn't treat symptoms directly. Instead, it facilitates the immediate availability of the active drug it is carrying. Its presence in the blood peaks shortly after injection and is typically metabolized within a few hours.
Yes, you can stop taking products containing Polysorbate 80 suddenly without experiencing any withdrawal symptoms from the Polysorbate itself. It is not a habit-forming substance and does not alter brain chemistry or hormonal balance. However, you should never stop a prescribed medication (like an injection for a chronic condition) without first consulting your doctor. The danger of stopping suddenly usually comes from the underlying disease returning, rather than any reaction to the removal of the Polysorbate 80 excipient.
If you miss a dose of a medication that contains Polysorbate 80, you should follow the specific 'missed dose' instructions for that particular medication. In most cases, this involves taking the missed dose as soon as you remember, unless it is almost time for your next scheduled dose. You should never take two doses at once to make up for a missed one. Since Polysorbate 80 is often part of an injection given by a nurse or doctor, you should call their office to reschedule your appointment as soon as possible to maintain your treatment schedule.
There is no clinical evidence to suggest that Polysorbate 80 causes weight gain. It is used in such minute quantities in medications that it contributes virtually zero calories to your daily intake. Even when used as a food additive, its caloric contribution is negligible. If you are experiencing weight gain while taking a medication that contains Polysorbate 80, it is likely due to the active drug (such as a corticosteroid), changes in your activity level, or your underlying medical condition. Discuss any unexpected weight changes with your healthcare provider.
Polysorbate 80 is already present in many different medications, and taking multiple products containing it is generally safe as long as you stay below the recommended daily intake. However, because it can increase the solubility and absorption of other substances, it can occasionally interact with how your body processes certain drugs. This is why it is vital to provide your doctor with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are using. Your pharmacist can also check for any potential 'excipient-drug' interactions that might be relevant to your specific health profile.
Polysorbate 80 is a chemical substance rather than a brand-name drug, so the concept of 'generic' doesn't apply in the traditional sense. It is manufactured by many different chemical companies under various trade names, the most common being Tween 80. When you see it listed on a medication label, it is simply the standardized name for that ingredient. You cannot buy Polysorbate 80 as a standalone 'generic' medication at a pharmacy because it has no therapeutic use on its own; it only exists as a component of other products.